Mark K. Oki
VP Fin, Controller & PAO, Alexza Pharmaceuticals Inc.
Companies
- ACHIEVE LIFE SCIENCES, INC.Chief financial officer Dec 9, 2024 to now1
- AYTU BIOPHARMA, INCChief financial officer Jan 19, 2022 to Aug 15, 20232
- VivusChief financial officer Oct 20, 2015 to Jan 31, 20203
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ACHIEVE LIFE SCIENCES, INC. ACHV127,940 shares4$816.3K at $6.38Sep 18, 2025
- AYTU BIOPHARMA, INC AYTU190,000 shares5$387.6K at $2.04Nov 18, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2025Sold 50,060 shares at $2.92 of ACHIEVE LIFE SCIENCES, INC.4
- Sep 18, 2025Exercised options 168,000 shares of ACHIEVE LIFE SCIENCES, INC.4
- Mar 17, 2025Bought 10,000 shares at $2.89 of ACHIEVE LIFE SCIENCES, INC.6
- Nov 18, 2022Bought 90,000 shares at $0.23 of AYTU BIOPHARMA, INC5
- Nov 18, 2022Granted 90,000 shares at $0.23 of AYTU BIOPHARMA, INC7
- Jan 17, 2022Granted 100,000 shares of AYTU BIOPHARMA, INC8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARVivus, Chief financial officer
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 19, 2025
- 7SEC EDGARForm 4 filed Nov 21, 2022
- 8SEC EDGARForm 4 filed Jan 19, 2022